AstraZeneca PLC Share Price & Technical Analysis

AZN · $187.1 (-1.41%)

Healthcare / Drug Manufacturers - General

AI Score 45 · Weak

$187.1

-1.41%

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendi

Price chart

Seasonality

May has 4 positive and 1 negative years (last 5 years shown)

1% return in May, 2% avg return in past 3 year May month.

1% return in 2026, 13% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
260%9%-4%-6%1%1%
257%8%-4%-3%4%-2%4%9%-4%2%13%-1%33%
240%-3%5%11%2%-1%2%10%-11%-9%-6%-3%-2%
23-5%1%7%5%0%-1%7%-5%-1%-5%2%4%9%
220%6%7%1%1%-1%3%-6%-11%7%13%-1%20%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 45/100

Weak · Emerging · Neutral

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; and a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$287.60B

P/E ratio

27.93

52W high

$212.7

52W low

$137.2

Volume

15,38,601

Beta

0.22

Related stocks in Healthcare

Frequently asked questions

What is AstraZeneca PLC share price today?
AstraZeneca PLC (AZN) last traded around $187.1 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does AZN have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AZN. Download the app for real-time alerts.
How can I analyze AstraZeneca PLC stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro